CHRISTOPHER TWOMEY
Profile
First Name
: CHRISTOPHER
Middle Name
:
Last Name
: TWOMEY
Related Companies
Titles
Company Name
Related People
DIRECTOR
DAVID BARKER, DAVID L. BARKER, DAVID L. BARKER, PH.D., MARK BORODKIN, DARREN CAI, DARREN CAI, PH.D., HAN CAO, ALKA CHAUBEY, ALKA CHAUBEY, PH.D., FACMG, JONATHAN DIXON, EDWARD L. ERICKSON, BRIAN HALAK, ERIK R. HOLMLIN, R. ERIK HOLMLIN, ROBERT ERIK HOLMLIN, R. ERIK HOLMLIN, PH.D., JOEL JUNG, JOEL R. JUNG, GULSEN KAMA, YVONNE LINNEY, YVONNE LINNEY, PH.D., LORRAINE G. LOPRESTI, ALBERT LUDERER, ALBERT A. LUDERER, ALBERT LUDERER, PH.D., ALBERT A. LUDERER, PH.D., HANNAH MAMUSZKA, GARTH MONROE, CAMPBELL MURRAY, MARK OLDAKOWSKI, JASON PRIAR, ALEKSANDAR RAJKOVIC, ALEKSANDAR RAJKOVIC, M.D., PH.D., WARREN ROBINSON, LYNNE ROLLINS, SOHEIL SHAMS, RICHARD SHIPPY, CHRISTOPHER STEWART, KRISTIINA VUORI, KRISTIINA VUORI, M.D., PH.D., JUNFENG WANG, MIKE WARD, TRACY WARREN, VINCENT WONG, VINCENT WONG, J.D., M.B.A., QUAN ZHOU
DIRECTOR
DAVID BARKER, DAVID L. BARKER, DAVID L. BARKER, PH.D., MARK BORODKIN, DARREN CAI, DARREN CAI, PH.D., HAN CAO, ALKA CHAUBEY, ALKA CHAUBEY, PH.D., FACMG, JONATHAN DIXON, EDWARD L. ERICKSON, BRIAN HALAK, ERIK R. HOLMLIN, R. ERIK HOLMLIN, ROBERT ERIK HOLMLIN, R. ERIK HOLMLIN, PH.D., JOEL JUNG, JOEL R. JUNG, GULSEN KAMA, YVONNE LINNEY, YVONNE LINNEY, PH.D., LORRAINE G. LOPRESTI, ALBERT LUDERER, ALBERT A. LUDERER, ALBERT LUDERER, PH.D., ALBERT A. LUDERER, PH.D., HANNAH MAMUSZKA, GARTH MONROE, CAMPBELL MURRAY, MARK OLDAKOWSKI, JASON PRIAR, ALEKSANDAR RAJKOVIC, ALEKSANDAR RAJKOVIC, M.D., PH.D., WARREN ROBINSON, LYNNE ROLLINS, SOHEIL SHAMS, RICHARD SHIPPY, CHRISTOPHER STEWART, KRISTIINA VUORI, KRISTIINA VUORI, M.D., PH.D., JUNFENG WANG, MIKE WARD, TRACY WARREN, VINCENT WONG, VINCENT WONG, J.D., M.B.A., QUAN ZHOU
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
2024-07-08
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Debt
2023-10-13
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2021-10-18
D
PHARMACEUTICALS
LABORATORY ANALYTICAL INSTRUMENTS [3826]
NOT APPLICABLE
Equity
2019-03-14
